Answers are grounded in this paper and cite their sources.
Purpose To evaluate clinical outcomes after maintenance therapy discontinuation in transplant-eligible multiple myeloma (MM) patients with measurable residual disease (MRD) negativity, identify predictors of post-discontinuation MRD resurgence, and assess salvage efficacy upon MRD recurrence. Methods This retrospective study enrolled 35 newly diagnosed MM patients treated at our center between January 2010 and January 2024. Patients received novel-agent induction, autologous stem cell transplantation, and maintenance therapy, which ceased after MRD negativity, were confirmed by multiparameter flow cytometry. The primary endpoint was MRD resurgence. Fine–Gray competing-risk regression was used to identify associated factors. Kaplan–Meier methods estimated treatment-free survival (TFS) and overall survival (OS). Results Median patient age was 53 years (range 35–67). Median duration from MRD negativity to maintenance cessation was 32.0 months; median post-discontinuation follow-up was 79.0 months. Fifteen patients (42.9%) developed MRD resurgence; 3- and 5-year cumulative incidence rates were 26.9% (95% CI 13.4–42.5%) and 37.4% (95% CI 21.1–53.8%), respectively. Using multivariable Fine-Grey analysis, high-risk cytogenetic abnormalities (HRCA)predicted higher MRD resurgence risk (HR 4.8, 95% CI 1.6–14.6, P = 0.005), whereas sustained MRD negativity ≥ 2 years before discontinuation reduced risk (HR 0.2, 95% CI 0.1–0.7, P = 0.012). Of 15 patients with MRD resurgence, 13 received salvage therapy and 10 (76.9%) regained MRD negativity. Median post-discontinuation TFS and OS were 67.3 and 80.0 months, respectively. Conclusion Maintenance discontinuation after MRD negativity is feasible in selected transplant-eligible MM patients. HRCA and sustained MRD negativity duration facilitate post-stop risk stratification. These exploratory findings require validation in larger multicenter cohorts.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: